March 4, 2006 by TP Admin
Posted in
Public Citizen, a non-profit consumer advocacy organization, petitioned the Food and Drug Administration to withdraw propoxyphene products (Darvon, Darvocet and generics) from the US market. The petition mentions the phased withdrawal in the United Kingdom which began a year ago. The UK government health authorities stated that the efficacy of this product "...is poorly established and the risk of toxicity in overdose, both accidental and deliberate, is unacceptable."